Medical Director Articles

The term "article" is used to describe any bulletin article, web site article, educational handout or any other non-LCD document intended for public release that contains coverage/coding statements or medical review related billing or claims considerations.

Articles address local coverage, coding or medical review related billing and claims considerations, and may include any newly developed educational materials, coding instructions or clarification of existing medical review related billing or claims policy.

The article listing will continue to expand as additions are made.

Last Updated Jan 30 , 2024
Articles Source Posted
Billing and Coding: Diagnostic and Therapeutic Colonoscopy (A57342)- R6 - Effective October 1, 2024 Jan 17, 2025
Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors (A58973)- R6 - Effective January 1, 2025 Jan 16, 2025
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57526)- R21 - Effective January 1, 2025 Jan 16, 2025
Billing and Coding: Trigger Point Injections (TPI) (A57701) - R6 - Effective April 1, 2024 Jan 16, 2025
Billing and Coding: Cervical Fusion (A59624) - R3 - Effective July 7, 2024 Jan 16, 2025
Multi-Jurisdictional CAC Meeting Announcement - Peripheral Nerve Blocks - February 3, 2025, 2 - 4 p.m. ET Jan 13, 2025
Multi-Jurisdictional Contractor Advisory Committee (CAC) Peripheral Nerve Blocks - Key Questions and References Jan 13, 2025
Multi-Jurisdictional Peripheral Nerve Blocks Contractor Advisory Committee (CAC) Meeting Agenda Jan 13, 2025
2025 MolDX CPT/HCPCS Billing and Coding Article Updates - Effective January 1, 2025 Jan 09, 2025
Billing and Coding: Hypoglossal Nerve Stimulation for Treatment of Obstructive Sleep Apnea (A57948) - R4 - Effective December 1, 2024 Jan 03, 2025
Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ) Final LCD - Effective February 16, 2025 Jan 02, 2025
Urine Drug Testing Final LCD - Effective February 16, 2025 Jan 02, 2025
Billing and Coding: Peripheral Nerve Stimulation (A55530) - R10 - Effective August 27, 2018 Jan 02, 2025
Billing and Coding: Implantable Infusion Pumps for Chronic Pain (A55239) - R19 - Effective January 1, 2025 Jan 02, 2025
Billing and Coding: Intraocular Bevacizumab (A53008) - R17 - Effective January 1, 2025 Jan 02, 2025
Self-Administered Drug Exclusion List (A53032) - R41 - Effective January 1, 2025 Jan 02, 2025
2025 CPT/HCPCS Billing and Coding Article Updates Jan 02, 2025
Billing and Coding: Facet Joint Interventions for Pain Management (A58403) - R6 - Effective January 1, 2025 Dec 26, 2024
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing: (A58720) - R22 - Effective September 13, 2024 Dec 05, 2024
Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer (A58718) - R4 - Effective November 28, 2024 Dec 02, 2024
Town Hall Meeting - December 10, 2024 Nov 21, 2024
Billing and Coding: Lab: Flow Cytometry (A57689) - R11 - Effective October 1, 2024 Nov 15, 2024
Billing and Coding: Sacral Nerve Stimulation for Urinary and Fecal Incontinence (A53359) - R11 - Effective October 1, 2024 Nov 15, 2024
Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers Final LCD - Effective February 12, 2025 Nov 14, 2024
Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers (A58996) - R8 - Effective July 11, 2024 Nov 14, 2024
MolDX: Blood Product Molecular Antigen Typing (L38331) - R5 - Effective November 7, 2024 Nov 07, 2024
Billing and Coding: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) (A57423) - R4 - Effective November 7, 2024 Nov 07, 2024
Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT )/Coronary Plaque Analysis (AI-CPA) Final LCD - Effective December 8, 2024 Oct 31, 2024
Billing and Coding: Lab: Cystatin C Measurement (A57643) - R5 - Effective January 1, 2023 Oct 24, 2024
Billing and Coding: MolDX: Pharmacogenomics Testing (A57384) - R14 - Effective August 1, 2024 Oct 24, 2024